Prevent Blindness & Regeneron Unite to Help Save Eyesight through “Diabetes and the Eyes” Program

(PRESS RELEASE) CHICAGO, IL — Prevent Blindness, the nation’s oldest voluntary eye health and safety organization, and Regeneron Pharmaceuticals, Inc., are uniting to increase education on the impact diabetes can have on vision and eye health through an expanded “Diabetes and the Eyes” program. With the support of Regeneron, the program will now include a video series relevant for both English and Spanish speakers, community-level health education and support, and refreshed materials to increase awareness of diabetes’ impact on vision.

Diabetes is one of the leading causes of vision loss and blindness in the nation due to the damage the disease can cause in eyes even before visual symptoms are noticeable. According to the 2022 National Diabetes Statistics Report from the Centers for Disease Control and Prevention, an estimated 37.3 million Americans have diabetes, and 23% of those people are unaware of their condition, which is an alarming statistic indicating nearly a quarter of people with diabetes are unaware of their risk for developing diabetes-related visual impairment.

“Diabetes continues to affect the lives of millions of Americans, and sadly, the number of cases continues to grow. The impact that diabetes may have on vision, as well as quality of life, can be devastating,” said Jeff Todd, president and CEO of Prevent Blindness. “We thank Regeneron for their continued support and partnership to help save sight and maintain independence through the ‘Diabetes and the Eyes’ program.”

Diabetes-related eye disease refers to a group of conditions that can affect people with diabetes, including diabetic retinopathy and diabetic macular edema. Prevent Blindness created the “Diabetes and the Eyes” program in 2019 to provide much-needed educational resources to allied health personnel and consumers with the goal of helping to prevent vision loss due to diabetes. In addition to the updated “Diabetes and the Eyes” toolkit, fact sheets and graphics, the support from Regeneron has allowed the program to expand and include the following:

“Prevention, early detection and timely treatment are all important components to help preserve vision in patients with diabetes-related eye diseases. It is imperative that we continue to arm our communities with the proper educational tools and resources to learn and understand the impact that diabetes can have on the eye,” said Alyson Berliner, Executive Medical Director, Clinical Sciences at Regeneron. “We are proud to support and work alongside Prevent Blindness on the ‘Diabetes and the Eyes’ program and further advance our commitment to the patient community.”

Author
Press Releases

You Might Also Enjoy...

It's here! Top Gun: Maverick

After more than 30 years of service as one of the Navy's top aviators, Pete "Maverick" Mitchell is where he belongs, pushing the envelope as a courageous test pilot and dodging the advancement in rank that would ground him.